16 October 2017
News and Views
Links and Services
June's issue of the Alimentary Pharmacology & Therapeutics examines the association between diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases.
Infections are an important concern in patients using immunosuppressive therapy for their inflamm
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors